Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane augmentation of alloreactive T cell function.

P Ruiz1, L Rey, R Spurney

  • 1Department of Pathology, University of Miami School of Medicine, FL 33101.

Transplantation
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Bradyrhizobium Sp. LmicA16 Type VI Secretion System Is Required for Efficient Nodulation of Lupinus Spp.

Microbial ecology·2021
Same author

Epigenetic control of the EWS‑FLI1 promoter in Ewing's sarcoma.

Oncology reports·2020
Same author

Phenolic and tannin compounds in subtropical shrubs (Bituminaria bituminosa, Chamaecytisus proliferus, and Adenocarpus foliosus) and the effects on in vitro digestibility.

Tropical animal health and production·2019
Same author

Effects of replacing rye-grass (Lolium spp.) hay by banana (Musa acuminata L.) by-products on feed intake, growth, and feed conversion rate of Canary hair sheep breed (Pelibuey) lambs.

Tropical animal health and production·2018
Same author

Emotion-regulation ability, role stress and teachers' mental health.

Occupational medicine (Oxford, England)·2017
Same author

Non-inferiority trial between two dry-powder inhalers containing fluticasone/salmeterol in asthmatic patients.

Drug research·2013
Same journal

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Transplantation·2026
Same journal

People in Transplantation: Professor Nadey Hakim, MD, PhD, FRCS, FRCSGlas (Hon), FACS, President-Elect of The Transplantation Society.

Transplantation·2026
Same journal

IL-1 Receptor Blockade Modulates Inflammation During Sequential Perfusion in Ex Vivo Porcine Kidneys.

Transplantation·2026
Same journal

Regulatory T Cells Allosensitized Under the Blockade of CD80/CD86-CD28 Costimulation Prolonged Islet Allograft Survival.

Transplantation·2026
Same journal

Desensitization With Tocilizumab and IVIg: A Prospective Controlled Cohort Study in a Predominantly Black American Population.

Transplantation·2026
Same journal

From Preservation to Repair: Clinical and Ethical Implications of Organ Reconditioning in the era of Machine Perfusion.

Transplantation·2026
See all related articles

Thromboxane (Tx) enhances immune T cell responses crucial for transplant rejection. Inhibiting Tx in vitro reduces alloreactive T cell proliferation, suggesting Tx is a key mediator in transplant rejection.

Area of Science:

  • Immunology
  • Transplantation immunology
  • Vascular biology

Background:

  • Thromboxane (Tx) is implicated in renal allograft dysfunction and rejection.
  • In vivo studies suggest Tx promotes cytotoxic T cell function within transplants.

Purpose of the Study:

  • To investigate the in vitro effects of Thromboxane inhibition on alloreactive immune cells.
  • To determine if Thromboxane inhibition modulates T cell responses in MHC-disparate mouse models.

Main Methods:

  • Coculture of mouse lymphoid populations with Thromboxane-synthetase or Thromboxane-receptor inhibitors.
  • Mixed Lymphocyte Reaction (MLR) assays to assess T cell proliferation and activation.
  • Measurement of Interleukin-2 production and T cell population percentages (CD4, CD8).

Related Experiment Videos

Main Results:

  • Thromboxane inhibition decreased proliferation of unprimed and primed alloreactive T cells in MLR.
  • In vitro addition of Thromboxane A2 augmented T cell responses.
  • CD4 and CD8 expression increased in Thromboxane inhibitor-treated populations, but IL-2 production was unaffected.

Conclusions:

  • Thromboxane acts as an immunoregulatory mediator, potentiating alloreactive T cell function.
  • Thromboxane inhibition demonstrates potential as a therapeutic strategy to mitigate transplant rejection.
  • These findings highlight Thromboxane's critical role in T cell-mediated transplant rejection.